ripk3 (ProSci Incorporated)


Structured Review

Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Necroptosis Underlies Neutrophilic Inflammation Associated with the Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)"
Article Title: Necroptosis Underlies Neutrophilic Inflammation Associated with the Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Journal: Journal of Inflammation Research
doi: 10.2147/JIR.S322875

Figure Legend Snippet: A working model illustrating the potential role of necroptosis in the pathogenesis of CRSwNP. The presence of TNF-α, IFN-γ and PAMPs in the nasal mucosa can cause RIPK3/MLKL dependent necroptosis and cell membrane rupture, which leads to the release of DAMPs such as IL-1α and ATP. DAMPs further stimulate the expression of proinflammatory cytokines and chemokines including IL-8 and CXCL1 to recruit neutrophils and exacerbate inflammation in CRSwNP.
Techniques Used: Expressing
ripk3 (ProSci Incorporated)


Structured Review

Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Necroptosis Underlies Neutrophilic Inflammation Associated with the Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)"
Article Title: Necroptosis Underlies Neutrophilic Inflammation Associated with the Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Journal: Journal of Inflammation Research
doi: 10.2147/JIR.S322875

Figure Legend Snippet: A working model illustrating the potential role of necroptosis in the pathogenesis of CRSwNP. The presence of TNF-α, IFN-γ and PAMPs in the nasal mucosa can cause RIPK3/MLKL dependent necroptosis and cell membrane rupture, which leads to the release of DAMPs such as IL-1α and ATP. DAMPs further stimulate the expression of proinflammatory cytokines and chemokines including IL-8 and CXCL1 to recruit neutrophils and exacerbate inflammation in CRSwNP.
Techniques Used: Expressing
rabbit anti ripk3 (ProSci Incorporated)


Structured Review

Rabbit Anti Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "RAGE interacts with the necroptotic protein RIPK3 and mediates transfusion-induced danger signal release"
Article Title: RAGE interacts with the necroptotic protein RIPK3 and mediates transfusion-induced danger signal release
Journal: Vox sanguinis
doi: 10.1111/vox.12946

Figure Legend Snippet: RAGE mediates DAMP release following transfusion and RAGE deletion attenuates necroptotic cell death. (a) Plasma HMGB1 and RIPK3 following RBC transfusion in WT and RAGE KO mice (n = 3 from 2 independent experiments and * P <0.002, **P = 0.023 for HMGB1; n = 3 from three independent experiments and *P = 0.003, **P = 0.02 for RIPK3). (b) HUVEC were treated with TNFα (100 ng/ml), LPS (10 ng/ml), or CpG (10 μg/ml) in the presence of zVAD for 4 h. RAGE knockdown led to a significant attenuation in cell death following TNFα-zVAD, LPS-zVAD and CpG-zVAD treatment (n = 4 from two independent experiments, P = 0.036 for TNFα, P = 0.035 for LPS, P = 0.005 for CpG). (c) RAGE and RIPK3 expression in naive or TNFα-ZVAD treated HMVEC-L. Proximity Ligation Assay of RAGE and RIPK3 in naive and TNFα-zVAD treated HMVEC-L, RAGE-RIPK3-RED, F-Actin-Green, DAPI-Blue.
Techniques Used: Expressing, Proximity Ligation Assay

Figure Legend Snippet: RAGE and RIPK3 are detected in the nucleus of HMVEC-L. (a) HMVEC-L were transfected with GFP-tagged RAGE. Anti-GFP beads were utilized to pulldown RAGE from membrane (M), nuclear (N) or cytosolic fractions (c). Immunoblotting for RAGE and RIPK3 was performed. (b) HMVEC-L were treated with TNFα-zVAD or RBC-zVAD for 4 h. Cell lysates were fractionated and probed for RIPK3 or RAGE. RAGE and RIPK3 were detected in all three compartments. (c) RAGE and RIPK3 expression in naive, RBC-zVAD, or TNFα-ZVAD treated HMVEC-L (n = 6 from two independent experiments, representative micrographs shown).
Techniques Used: Transfection, Western Blot, Expressing
rabbit anti ripk3 (ProSci Incorporated)


Structured Review

Rabbit Anti Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "RAGE interacts with the necroptotic protein RIPK3 and mediates transfusion-induced danger signal release"
Article Title: RAGE interacts with the necroptotic protein RIPK3 and mediates transfusion-induced danger signal release
Journal: Vox sanguinis
doi: 10.1111/vox.12946

Figure Legend Snippet: RAGE mediates DAMP release following transfusion and RAGE deletion attenuates necroptotic cell death. (a) Plasma HMGB1 and RIPK3 following RBC transfusion in WT and RAGE KO mice (n = 3 from 2 independent experiments and * P <0.002, **P = 0.023 for HMGB1; n = 3 from three independent experiments and *P = 0.003, **P = 0.02 for RIPK3). (b) HUVEC were treated with TNFα (100 ng/ml), LPS (10 ng/ml), or CpG (10 μg/ml) in the presence of zVAD for 4 h. RAGE knockdown led to a significant attenuation in cell death following TNFα-zVAD, LPS-zVAD and CpG-zVAD treatment (n = 4 from two independent experiments, P = 0.036 for TNFα, P = 0.035 for LPS, P = 0.005 for CpG). (c) RAGE and RIPK3 expression in naive or TNFα-ZVAD treated HMVEC-L. Proximity Ligation Assay of RAGE and RIPK3 in naive and TNFα-zVAD treated HMVEC-L, RAGE-RIPK3-RED, F-Actin-Green, DAPI-Blue.
Techniques Used: Expressing, Proximity Ligation Assay

Figure Legend Snippet: RAGE and RIPK3 are detected in the nucleus of HMVEC-L. (a) HMVEC-L were transfected with GFP-tagged RAGE. Anti-GFP beads were utilized to pulldown RAGE from membrane (M), nuclear (N) or cytosolic fractions (c). Immunoblotting for RAGE and RIPK3 was performed. (b) HMVEC-L were treated with TNFα-zVAD or RBC-zVAD for 4 h. Cell lysates were fractionated and probed for RIPK3 or RAGE. RAGE and RIPK3 were detected in all three compartments. (c) RAGE and RIPK3 expression in naive, RBC-zVAD, or TNFα-ZVAD treated HMVEC-L (n = 6 from two independent experiments, representative micrographs shown).
Techniques Used: Transfection, Western Blot, Expressing
anti ripk3 (ProSci Incorporated)


Structured Review

Anti Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "A phosphorylation of RIPK3 kinase initiates an intracellular apoptotic pathway that promotes prostaglandin 2α -induced corpus luteum regression"
Article Title: A phosphorylation of RIPK3 kinase initiates an intracellular apoptotic pathway that promotes prostaglandin 2α -induced corpus luteum regression
Journal: eLife
doi: 10.7554/eLife.67409

Figure Legend Snippet: ( A ) Cultured MCF7/TO-RIPK3 and HeLa/TO-RIPK3 cells were treated with DMSO or Dox (1 μg/ml) induction for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The cell lysates were analyzed by western blotting using antibodies against RIPK3 or β-actin (lower panel). ( B ) Cultured MCF7/TO-RIPK3, KGN/TO-RIPK3, and HeLa/TO-RIPK3 cells were treated with DMSO, Dox, or Dox plus TSZ for 36 hr. Cell viability was determined by measuring cellular ATP levels. The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. ( C ) Cultured MCF7/TO-RIPK3 cells were treated with DMSO or Dox, plus the indicated agents for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The cell lysates were analyzed by western blotting using antibodies against RIPK3 or β-actin (lower panel). 20 μM Z, pan-caspase inhibitor z-VAD; 2 μM RIPA-56, RIPK1 inhibitor; 2 μM NSA, MLKL inhibitor. ( D ) Cultured MCF7 cells were infected with lentiviruses encoding RIPK3(WT), RIPK3(AAAA), RIPK3(K50A), and RIPK3(K50A)+GSK’872 plus Z for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The lysates were measured by western blotting using antibodies against RIPK3 or β-actin as indicated (lower panel). GSK’872, RIPK3 inhibitor.
Techniques Used: Cell Culture, Western Blot, Infection

Figure Legend Snippet: Cultured KGN/TO-RIPK3 cells were treated with DMSO or Dox (1 μg/ml) induction for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The cell lysates were analyzed by western blotting using antibodies against RIPK3 or β-actin (lower panel).
Techniques Used: Cell Culture, Western Blot
![( A ) Cultured MCF7/TO-RIPK3 cells were treated with DMSO or Dox plus ... ( A ) Cultured MCF7/TO-RIPK3 cells were treated with DMSO or Dox plus the indicated agent for 24 hr. The cells were then harvested, and RIPK3 was immunoprecipitated from the cell lysates using anti-Flag resin. The cell lysates and immunocomplexes were analyzed by western blotting using antibodies as indicated. ( B–E ) Cultured MCF7/TO-RIPK3 (wild type [WT], RIPK1 -/- , Caspase8 -/- , FADD -/- , and cFLIF -/- ) cells were treated with DMSO or Dox induction for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. *p<0.05, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The cell lysates were analyzed by western blotting using antibodies against RIPK1, caspase-8, FADD, cFLIP, or β-actin (lower panel). Five independent knockout clones were test in each gene.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3796/pmc08143796/pmc08143796__elife-67409-fig2.jpg)
Figure Legend Snippet: ( A ) Cultured MCF7/TO-RIPK3 cells were treated with DMSO or Dox plus the indicated agent for 24 hr. The cells were then harvested, and RIPK3 was immunoprecipitated from the cell lysates using anti-Flag resin. The cell lysates and immunocomplexes were analyzed by western blotting using antibodies as indicated. ( B–E ) Cultured MCF7/TO-RIPK3 (wild type [WT], RIPK1 -/- , Caspase8 -/- , FADD -/- , and cFLIF -/- ) cells were treated with DMSO or Dox induction for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. *p<0.05, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The cell lysates were analyzed by western blotting using antibodies against RIPK1, caspase-8, FADD, cFLIP, or β-actin (lower panel). Five independent knockout clones were test in each gene.
Techniques Used: Cell Culture, Immunoprecipitation, Western Blot, Knock-Out, Clone Assay

Figure Legend Snippet: ( A ) Cultured MCF7/TO-RIPK3 and HeLa/TO-RIPK3 cells were treated with Dox plus z-VAD for 24 hr. RIPK3 was immunoprecipitated from the cell lysates using anti-Flag resin. The RIPK3 bands were excised and subjected to mass spectrometry analysis. RIPK3-specific phosphorylation site in MCF7/TO-RIPK3 cells is highlighted in red. ( B ) Cultured KGN/TO-RIPK3, MCF7/TO-RIPK3, and HeLa/TO-RIPK3 cells were treated with Dox plus z-VAD for 24 hr. The lysates were analyzed by western blotting using antibodies against the phospho-serine 164/threonine 165 of RIPK3, Flag (RIPK3), and β-actin as indicated. ( C ) Cultured MCF7 stably transfected with either wild-type RIPK3 (WT) or kinase-dead mutant (D160N) cells under the control of Dox-inducible promoter were treated with DMSO(-) or Dox plus z-VAD for 24 hr. The lysates were analyzed by western blotting using antibodies against the phospho-serine 164/threonine 165 RIPK3, Flag (RIPK3), and β-actin as indicated. ( D ) Cultured 293T cells were transfected with Vector (Vec), RIPK3(WT), RIPK3(D160N), RIPK3(AAAA) (RIPK3-AAAA, residues 459–462 mutated to AAAA), and RIPK3(S164D/T165E) for 24 hr. The level of phospho-S227-RIPK3 and RIPK3 was measured by western blotting. ( E, F ) Cultured MCF7 ( E ) and KGN ( F ) cells were infected with lentiviruses encoding RIPK3(WT), RIPK3(S164D/T165E), RIPK3(S164A/T165A), and RIPK3(AAAA) plus z-VAD for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The lysates were measured by western blotting using antibodies against RIPK3 or β-actin as indicated (lower panel). ( G ) Cultured HeLa cells were infected with lentiviruses encoding RIPK3(WT), RIPK3(D160N), RIPK3(AAAA), and RIPK3(S164D/T165E) plus z-VAD for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. **p<0.01, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The expressed RIPK3 in the cell lysates were measured by western blotting using antibodies against RIPK3 or β-actin as indicated (lower panel). Vector (Vec, control viruses) ( H ) Cultured HeLa cells were transfected with Flag-tagged RIPK3(WT), RIPK3(D160N), and RIPK3(S164D/T165E) for 24 hr. RIPK3 was immunoprecipitated using anti-Flag resin. The lysates and immunocomplexes were analyzed by western blotting using antibodies against RIPK1, caspase-8, FADD, and RIPK3 as indicated. ( I ) Cultured MCF7/TO-RIPK3 and MCF7/TO-RIPK3(S164A/T165A) cells were treated with Dox plus Z for 24 hr. The cells were then harvested, and RIPK3 was immunoprecipitated from the cell lysates using anti-Flag resin. The cell lysates and immunocomplexes were analyzed by western blotting using antibodies as indicated.
Techniques Used: Cell Culture, Immunoprecipitation, Mass Spectrometry, Western Blot, Stable Transfection, Transfection, Mutagenesis, Plasmid Preparation, Infection

Figure Legend Snippet: ( A ) Cultured MCF7/TO-RIPK3 and MCF7/TO-RIPK3(S164A/T165A) cells were treated with DMSO(-) or Dox plus z-VAD for 24 hr. The lysates were analyzed by western blotting using antibodies against the phospho-serine 164/threonine 165 of RIPK3, Flag (RIPK3), and β-actin as indicated. ( B ) Cultured KGN7/TO-RIPK3 and KGN/TO-RIPK3(S164A/T165A) cells were treated with DMSO or Dox plus z-VAD for 24 hr. The lysates were analyzed by western blotting using antibodies against the phospho-serine 164/threonine 165 of RIPK3, Flag (RIPK3), and β-actin as indicated. ( C ) Cultured MCF7/TO-RIPK3 and MCF7/TO-RIPK3(K50A) cells were treated with DMSO(-) or Dox plus z-VAD for 24 hr. The lysates were analyzed by western blotting using antibodies against the phospho-serine 164/threonine 165 of RIPK3, Flag (RIPK3), and β-actin as indicated. ( D ) Cultured HeLa cells were infected with lentiviruses encoding wild-type RIPK3(WT), and mutant RIPK3 including RIPK3(D160N), RIPK3(S164D/T165E), RIPK3(S164E), RIPK3(T165E), RIPK3(S164A/T165A), RIPK3(S164A), RIPK3(T165A), and RIPK3(AAAA) and treated with TSZ for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. **p<0.01. p-values were determined by two-sided unpaired Student’s t -tests. The levels of expressed RIPK3 in the cell lysates were measured by western blotting (lower panel). ( E ) RIPK3 single site (S164E) mutation blocks auto-phosphorylation. 293T cells were transfected with Flag-tagged RIPK3(WT), RIPK3(D160N), RIPK3(S164D/T165E), RIPK3(S164E), RIPK3(T165E), RIPK3(S164A/T165A), RIPK3(S164A), RIPK3(T165A), and RIPK3(AAAA) for 24 hr. The level of p-S227-RIPK3 and RIPK3 was measured by western blotting. ( F, G ) Cultured MCF7 ( E ) and KGN ( F ) cells were infected with lentiviruses encoding wild-type RIPK3(WT), and mutant forms of RIPK3(S164A/T165A), RIPK3(S164A), and RIPK3(T165A) and treated with z-VAD as indicated for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The levels of RIPK3 in the cell lysates were measured by western blotting (lower panel). ( H ) Cultured HeLa cells were transfected with Flag-tagged wild-type RIPK3(WT), and mutant forms of RIPK3(T165E), RIPK3(S164D/T165E), and RIPK3(S164E) for 24 hr. RIPK3 was immunoprecipitated from the cell lysates using anti-Flag resin. The lysates and immunocomplexes were analyzed by western blotting using antibodies against RIPK1, caspase-8, RIPK3, and β-actin as indicated.
Techniques Used: Cell Culture, Western Blot, Infection, Mutagenesis, Transfection, Immunoprecipitation

Figure Legend Snippet: ( A ) The cell lysates from cultured HT29, HeLa, MCF7, and KGN cells were analyzed by western blotting using antibodies as indicated. ( B, C ) Cultured HeLa-RIPK3, MCF7/TO-RIPK3, and KGN/TO-RIPK3 cells were treated with the indicated stimuli for 36 hr. Cell viability was determined by measuring cellular ATP levels. The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. 17AAG, Hsp90 inhibitor. ( D, E ) HeLa/TO-RIPK3 cells were treated with the indicated stimuli for 36 hr. Cell viability was determined by measuring cellular ATP levels in ( D ). The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. 24 hr after treatment, the cell lysates were analyzed by western blotting using antibodies against phospho-serine 164/threonine 165 of RIPK3, RIPK3, and β-actin as indicated in ( E ). ( F, G ) Cultured MCF7/TO-RIPK3 cells co-transfected with HSP90 and CDC37 as indicated were treated with DMSO or Dox for 36 hr. Cell viability was determined by measuring cellular ATP levels in ( F ). The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. 24 hr after treatment, the cell lysates were analyzed by western blotting using antibodies against phospho-serine 164/threonine 165 of RIPK3, RIPK3, Hsp90, CDC37, and β-actin as indicated in ( G ). ( H ) Cultured HeLa/TO-RIPK3 cells were treated with Dox or Dox plus 17AAG for 24 hr. The cells were then harvested, and RIPK3 was immunoprecipitated from the cell lysates using anti-Flag resin. The cell lysates and immunocomplexes were analyzed by western blotting using antibodies as indicated. ( I ) Cultured HeLa/TO-RIPK3 cells were treated with Dox or Dox plus 17AAG for 24 hr. Immunofluorescence of the cells with Flag-RIPK3 (red) antibody. Counterstaining with DAPI (blue). Scale bar, 10 μm. Higher-power views (right panels) were acquired from the selected boxed areas from the left panel. ( J ) Cultured MCF7/TO-RIPK3 cells co-transfected with HSP90 and CDC37 as indicated were treated with Dox for 24 hr. Immunofluorescence of the cells with Flag-RIPK3 (red) antibody. Counterstaining with DAPI (blue). Scale bar, 10 μm. Higher-power views (right panels) were acquired from the selected boxed areas from the left panel.
Techniques Used: Cell Culture, Western Blot, Transfection, Immunoprecipitation, Immunofluorescence

Figure Legend Snippet: ( A ) HeLa/TO-RIPK3 and HeLa/TO-RIPK3-shRNA-HSP90 cells were treated with the indicated stimuli for 36 hr. Cell viability was determined by measuring cellular ATP levels. The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The cell lysates were analyzed by western blotting using antibodies as indicated (right panel). ( B ) L929 cells were treated with the indicated stimuli for 5 hr. Cell viability was determined by measuring cellular ATP levels. The data are represented as the mean ± SD of triplicate wells. ( C ) L929( Ripk3 -/- )/TO-RIPK3 and L929( Ripk3 -/- )/TO-RIPK3-shRNA-HSP90 cells were treated with the indicated stimuli for 36 hr. Cell viability was determined by measuring cellular ATP levels. The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. The cell lysates were analyzed by western blotting using antibodies as indicated (right panel). ( D, E ) L929( Ripk3 -/- )/TO-RIPK3 cells were treated with the indicated stimuli for 36 hr. Cell viability was determined by measuring cellular ATP levels in ( D ). The data are represented as the mean ± SD of triplicate wells. **p<0.01, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. 24 hr after treatment, the cell lysates were analyzed by western blotting using antibodies against phospho-serine 165/threonine 166 of RIPK3, RIPK3, and β-actin as indicated in ( E ).
Techniques Used: shRNA, Western Blot

Figure Legend Snippet: ( A ) Alignment of amino acid sequences of RIPK3 orthologs in five mammalian species. Amino acid residues conserved in 80% or more of the sequences are shaded in black. The putative phosphorylation residues are denoted by asterisks (*). ( B ) Cultured 293T cells were transfected with Vector (Vec), mouse RIPK3(WT), RIPK3(S165D/T166E), and RIPK3(S165A/T165A) for 24 hr. The level of phospho-S232-RIPK3 and RIPK3 was measured by western blotting. ( C ) Cultured mouse sarcoma cells L929( Ripk3 -/- ) were transfected with Vector, wild-type mouse RIPK3, and mutant forms of mRIPK3(D161N), and mRIPK3(S165D/T166E) and treated with z-VAD or TSZ as indicated for 36 hr. Cell viability was determined by measuring cellular ATP levels (upper panel). The data are represented as the mean ± SD of triplicate wells. **p<0.01. p-values were determined by two-sided unpaired Student’s t -tests. The lysates were analyzed by western blotting using antibodies as indicated (lower panel).
Techniques Used: Cell Culture, Transfection, Plasmid Preparation, Western Blot, Mutagenesis

Figure Legend Snippet: ( A ) Cultured HeLa/TO-RIPK3 and MCF7/TO-RIPK3 cells were treated with DMSO or Dox plus TSZ for 24 hr. Immunofluorescence of the cells with Flag-RIPK3 (green) antibody. Counterstaining with DAPI (blue). Scale bar, 10 μm. Higher-power views (right panels) were acquired from the selected boxed areas from the left panel. ( B ) Cultured HT29 and KGN/TO-RIPK3 cells were treated with DMSO, TSZ, or Dox for 24 hr. Immunofluorescence of the cells with Flag-RIPK3 (green) antibody. Counterstaining with DAPI (blue). Scale bar, 10 μm. Higher-power views (right panels) were acquired from the selected boxed areas from the left panel. ( C ) Cultured HeLa/TO-RIPK3 and MCF7/TO-RIPK3 cells were treated with Dox plus Z for 24 hr. Immunofluorescence of the cells with Flag-RIPK3 (red) and p-S164/T165-RIPK3 (green) antibody. Counterstaining with DAPI (blue). Scale bar, 10 μm. Higher-power views (right panels) were acquired from the selected boxed areas from the left panel. ( D ) Cultured MCF7/TO-RIPK3(WT, RIPK1 -/- , caspase-8 -/- and FADD -/- ) cells were treated with Dox plus Z for 24 hr. Immunofluorescence of the cells with Flag-RIPK3 (red) and p-S164/T165-RIPK3 (green) antibody. Counterstaining with DAPI (blue). Scale bar, 10 μm. Higher-power views (right panels) were acquired from the selected boxed areas from the left panel. ( E ) Cultured MCF7/TO-RIPK3(WT, RIPK1 -/- , caspase-8 -/- and FADD -/- ) cells were treated with DMSO or Dox plus Z for 24 hr. The lysates were analyzed by western blotting using antibodies as indicated.
Techniques Used: Cell Culture, Immunofluorescence, Western Blot

Figure Legend Snippet: ( A ) Two guide RNA and donate oligo sequences of Ripk3(S165D/T166E) and Ripk3(S165A/T166A) knock-in mice. ( B ) Schematic of CRISPER-Cas9 strategy for the generation for Ripk3(S165D/T166E) and Ripk3(S165A/T166A) knock-in mice. The gene structure of RIPK3 and two guide RNA sequences targeting the exon 4 of RIPK3 is shown with the PAM sequences highlighted in red and blue. ( C, D ) Macroscopic features ( C ) and body weights ( D ) of Ripk3 +/+ and Ripk3 ST-AA/ST-AA littermate mice at 14 days of age (n = 10). The result from each individual animal is presented as an indicated dot. NS: not significant. p-values were determined by two-sided unpaired Student’s t -tests. ( E, F ) Immunoblot of RIPK3 from lung extracts of 14 days old Ripk3 +/+ , Ripk3 ST-DE/ST-DE , and Ripk3 ST-AA/ST-AA littermates using antibodies against RIPK3 and GAPDH as indicated (n = 3). ( G ) Histological analysis of brain, cerebellum, heart, kidney, and liver of Ripk3 +/+ and Ripk3 ST-DE/ST-DE littermate mice (n = 5) at 14 days of age. Scale bar, 20 μm. PTC: proximal tubular cell. ( H ) Cell viability measurement of bone marrow-derived macrophages from the Ripk3 +/+ and Ripk3 ST-AA/ST-AA littermate mice (n = 3, 14 days) after treatment with the indicated necroptosis stimuli for 24 hr. Cell viability was determined by measuring cellular ATP levels. The data are represented as the mean ± SD of triplicate wells.
Techniques Used: Knock-In, Western Blot, Derivative Assay

Figure Legend Snippet: ( A, B ) Macroscopic features ( A ) and body weights ( B ) of Ripk3 +/+ and Ripk3 ST-DE/ST-DE littermate mice at 14 days of age (n ≥ 9). The result from each individual animal is presented as an indicated dot. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. ( C ) Kaplan–Meier plot of survival of Ripk3 +/+ and Ripk3 ST-DE/ST-DE littermate mice (n = 10 for each genotype) after birth within 2 months. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. ( D ) Histological analysis of large intestine, small intestine, lung, and spleen of Ripk3 +/+ and Ripk3 ST-DE/ST-DE littermate mice (n = 5) at 14 days of age. Scale bar, 20 μm. ( E, F ) Representative immunohistochemistry (IHC) images of the large intestine, small intestine, lung, and spleen of Ripk3 +/+ and Ripk3 ST-DE/ST-DE littermate mice (n = 5, 14 days) stained with a cleaved-caspase-3 (C–C3) antibody in ( E ). C-C3-positive cells were counted in two fields per organ and quantified in ( F ). Scale bar, 10 μm. Data represent the mean ± s.e.m. **p<0.01, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. ( G ) Cell viability measurement of bone marrow-derived macrophages from the Ripk3 +/+ and Ripk3 ST-DE/ST-DE littermate mice (n = 3, 14 days) after treatment with the indicated Z-VAD or necroptosis stimuli for 24 hr. Cell viability was determined by measuring cellular ATP levels. The data are represented as the mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. .
Techniques Used: Immunohistochemistry, Staining, Derivative Assay

Figure Legend Snippet: ( A ) Western blot analysis of RIPK1, RIPK3, and MLKL levels in perfused mouse ovary extracts of different ages. Each group is representative of at least three mice. ( B ) H&E and immunofluorescence (IF) imaging of an 8-month-old ovary. Two adjacent sections were analyzed. One section was stained with H&E, and the other was IF stained with a RIPK3 antibody (red) and DAPI (blue). Scale bar, 500 μm. Higher-power views of selected areas were acquired in a (primordia follicle), b (secondary follicle), c (corpus luteum), and d (corpus albicans) as indicated. PF: primary follicle; CL: corpus luteum; CA: corpus albicans. ( C ) Ovarian PGF 2α levels of wild-type mice (n = 8) at the indicated age assayed by ELISA. Data represent the mean ± s.e.m. **p<0.01, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. ( D ) Immunofluorescence images of a RIPK3 C-terminus HA-3xFlag knock-in mouse ovary (n = 5; 12 months) stained with antibodies against prostaglandin F receptor (PTGFR, green) and Flag (red). Counterstaining with DAPI (blue). Scale bar, 500 μm. Higher-power views (right panels) were acquired from the indicated boxed area in the second lower left panel. CL: corpus luteum; CA: corpus albicans. Scale bar, 100 μm. ( E ) Western blot analysis of p-S164/T165-RIPK3 and RIPK3 levels in extracts from perfused ovaries prepared from mice at the indicated age. Each group is representative of at least three mice. ( F ) Immunofluorescence images of ovaries from Ripk3 +/+ and Ripk3 -/- mice (4 months, 8 months and 12 months; n = 3) at the indicated ages stained with the p-S164/T165-RIPK3 antibody (red). Counterstaining with DAPI (blue). Scale bar, 200 μm. Higher-power views (lower two panels) were acquired from the selected boxed areas from the upper panel. a (CL), b (CL), c (CL, CA), and d (CL). F: follicle; CL: corpus luteum; CA: corpus albicans. Scale bar, 100 μm.
Techniques Used: Western Blot, Immunofluorescence, Imaging, Staining, Enzyme-linked Immunosorbent Assay, Knock-In

Figure Legend Snippet: ( A ) Schematic of CRISPER-Cas9 strategy for RIPK3 C-terminus HA-3xFlag knock-in mice. The gene structure of RIPK3 and guide RNA sequences targeting the Ripk3 is shown with the PAM sequences highlighted in red. ( B ) Western blotting analysis using protein extracts from the ovary of wild-type, heterozygous knock-in, and homozygous knock-in mice generated as illustrated in ( A ). ( C ) Schematic of CRISPER-Cas9 strategy for the generation for Ptgfr -/- mice. The gene structure of prostaglandin F receptor (PTGFR) and two guide RNA sequences targeting the Ptgfr is shown with the PAM sequences highlighted in red. ( D ) Immunoblot of PTGFR from ovary extracts of 2-month-old Ptgfr +/+ and Ptgfr -/- littermates using antibodies against PTGFR and GAPDH as indicated (n = 3).
Techniques Used: Knock-In, Western Blot, Generated

Figure Legend Snippet: ( A, B ) Immunofluorescence of ovary from wild-type mice (8 months; n = 3) with RIPK3 (red) and HSP90 (green) antibody in ( A ). Higher-power views of selected areas were acquired in right panel. The HSP90/RIPK3 levels were quantified in ( B ). F: follicle; CA: corpus albicans. Scale bar, 100/200 μm. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. ( C, D ) Immunofluorescence of ovary from wild-type mice (8 months; n = 3) with RIPK3 (red) and CDC37 (green) antibody in ( C ). Higher-power views of selected areas were acquired in right panel. The CDC37/RIPK3 levels were quantified in ( D ). F: follicle; CA: corpus albicans. Scale bar, 200 μm. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests.
Techniques Used: Immunofluorescence

Figure Legend Snippet: ( A – C ) Primary granulosal lutein cells (WT, Ripk3 -/- ) were isolated from 3-month-old mice ovaries. The cells were treated with dinoprost tromethamine (DT) at the indicated concentration for 36 hr in ( A ); with 1.5 μM DT at the indicated time in ( B ); or with 1.5 μM DT for 36 hr in ( C ). The cell lysates from the DT-treated cells were analyzed by western blotting using antibodies as indicated. ( D, E ) Ptgfr +/+ and Ptgfr -/- littermate female mice (n = 16; 25–26 days) were given 7.5 IU pregnant mare serum gonadotropin (PMSG) intraperitoneally (IP) followed by 7.5 IU serum gonadotropin and chorionic gonadotropin (SCG) 46 hr later to synchronize ovulation. The animals were then injected with DT (10 μg, IP) or saline 24 hr post-ovulation. Ovaries were then collected 12 hr later and stained with anti-RIPK3 antibody (red) in ( D ). The ovary lysates were analyzed by western blotting using antibodies as indicated in ( E ). * indicates corpus luteum. Counterstaining with DAPI (blue). Scale bar, 500 μm. ( F, G ) wild-type (WT), Ripk3 -/- , Ripk3 S165A-T166A/S165A-T166A , Fadd -/- Mlkl -/- and Ptgfr -/- female mice (each group, n = 16; 25–26 days) were treated as in ( D, F ). Ovaries from each group were then collected 24 hr after injecting with DT and stained with anti-cleaved-caspase-3 antibody in ( F ). The Cleaved-Caspase3 + cells were counted in five fields per ovary CL and quantified in ( G ). Scale bar, 20 μm. Data represent the mean ± s.e.m. **p<0.01, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. ( H ) WT female mice (n = 3; 25–26 days) were treated as in ( D, F ). Ovaries were then collected 12 hr after injecting with DT and stained with anti-cleaved-caspase-3 (red) and p-S164/T165-RIPK3 (green) antibody. Counterstaining with DAPI (blue). Scale bar, 100 μm.
Techniques Used: Isolation, Concentration Assay, Western Blot, Injection, Staining

Figure Legend Snippet: ( A ) Primary granulosal lutein cells were isolated from the 3-month-old mice ovary. The cells were then treated with 1 μM dinoprost tromethamine (DT) or plus MAPK inhibitors PD-98059 (5 μM) and U0126 (5 μM) as indicated for 36 hr. The lysates were analyzed by western blotting using antibodies as indicated. ( B ) Primary granulosal lutein cells were isolated from 3-month-old mice ovaries. The cells were treated with 1 μM DT at the indicated time. The cell lysates from the DT-treated cells were analyzed by western blotting using antibodies as indicated. ( C ) Diagram of induction of corpus luteum regression in vivo. ( D ) Ripk3 +/+ and Ripk3 S165A-T166A/S165A-T166A and littermate female mice (n = 3; 25–26 days) were given 7.5 IU pregnant mare serum gonadotropin (PMSG) intraperitoneally (IP) followed by 7.5 IU serum gonadotropin and chorionic gonadotropin (SCG) 46 hr later to synchronize ovulation. The animals were then injected with DT (10 μg, IP) or saline 24 hr post-ovulation. The ovary lysates were analyzed by western blotting using antibodies as indicated.
Techniques Used: Isolation, Western Blot, In Vivo, Injection

Figure Legend Snippet:
Techniques Used: Recombinant, Software
anti ripk3 (ProSci Incorporated)


Structured Review

Anti Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense"
Article Title: Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense
Journal: Cell
doi: 10.1016/j.cell.2020.03.040

Figure Legend Snippet: (A) Schematic depiction of the domains in mouse CASP6 and RIPK3 in the full-length construct (F), N-terminal construct (N), and C-terminal construct (C). The aspartic acid sites shown denote the mouse CASP6 cleavage sites, and the cysteine denotes the catalytic site. L, large subunit; RHIM, receptor-interacting protein homotypic interaction motif; S, small subunit.
Techniques Used: Construct

Figure Legend Snippet: KEY RESOURCES TABLE
Techniques Used: Recombinant, Transfection, Protease Inhibitor, SYBR Green Assay, Multiplex Assay, Enzyme-linked Immunosorbent Assay, Plasmid Preparation, Software
ripk3 (ProSci Incorporated)


Structured Review

Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "TRIM21, a New Component of the TRAIL-Induced Endogenous Necrosome Complex"
Article Title: TRIM21, a New Component of the TRAIL-Induced Endogenous Necrosome Complex
Journal: Frontiers in Molecular Biosciences
doi: 10.3389/fmolb.2021.645134

Figure Legend Snippet: TRAIL/z-VAD-fmk/Birinapant (TzB) induces necroptosis and necrosome formation in HT29 cells. (A) HT29 cells were pretreated with vehicle (DMSO 0.1%), Necrostatin-1 (Nec1, 10 µM) or Necrosulfonamide (NSA, 1 µM) for 1 h. Cells were then treated with TzB (in grey) or not (NT, in white) for 24 h. Percentage of PI positive dead cells were measured by flow cytometry (mean ± SD, n = 3). (###), p < 0.001 compared treated cells to NT cells; (***), p < 0.001 compared treated conditions. (B) HT29 cells were treated or not (0 min) with TRAIL-SK (500 ng/ml), z-VAD-fmk (25 µM) and Birinapant (Bp, 1 µM) for the indicated times. Four mg of cell lysates were immunoprecipitated (IP) with RIPK1 or RIPK3 antibody or control IgG. The RIPK1 or RIPK3 immunocomplexes were analyzed by western blot. *: an upper band for RIPK3 or a smear for RIPK1. Anti-human β-actin antibody was used as protein loading control. Representative data of three independent experiments. (C) Label-free quantification of protein of interest by mass spectrometry. Weighted spectral counts were calculated (means ± SD, n = 2) from the analysis of two different pools of eight RIPK3 immunoprecipitates for RIPK3, MLKL, RIPK1, FADD, Caspase 8, HS90B, TRIM21, and PGAM5 observed in IgG control (aIgG) and at times 0 and 3 h post-stimulation. (**) p < 0.01.
Techniques Used: Flow Cytometry, Immunoprecipitation, Western Blot, Mass Spectrometry

Figure Legend Snippet: RIPK1, MLKL, P-MLKL, and TRIM21 are recruited to the endogenous RIPK3-dependent necrosome. HT29 cells were treated or not (0 min) with TRAIL-SK (500 ng/ml), z-VAD-fmk (25 µM), and Birinapant (Bp, 1 µM) (TzB) for the indicated times. Four mg of cell lysates were immunoprecipitated (IP) with RIPK3 antibody or control IgG as described in materials and methods. Upper panel: RIPK3 immunocomplexes were analyzed for indicated proteins by immunoblotting. *: an upper band for RIPK3 or a smear for RIPK1. Lower panel: expression of the indicated proteins was analyzed in the total cell lysates (input) by immunoblotting. Anti-human β-actin antibody was used as protein loading control. Representative data of three independent experiments.
Techniques Used: Immunoprecipitation, Western Blot, Expressing

Figure Legend Snippet: Downregulation or overexpression of TRIM21 expression negatively or positively regulates TRAIL/z-VAD-fmk/Birinapant (TzB)-induced necroptosis, respectively. (A) HT29 and HaCat cells were transiently transfected with siTRIM21 or siNT1 (negative control). Immunoblot analysis of TRIM21, RIPK1, RIPK3, and MLKL expressions was carried out 72 h post-transfection. Anti-human Hsc70 antibody was used as protein loading control. Representative data of three independent experiments. (B) Forty eight hours after siRNA transfections, HT29, and HaCat cells were treated (in grey) or not (in white) with TRAIL-SK (100 ng/ml), z-VAD-fmk (25 µM) and Birinapant (Bp, 1 µM) (TzB) for 24 h. Percentages of necrotic cells (propidium iodide (PI) positive) were estimated (means ± SD, n = 3). (C) HT29 and HaCat cells were transiently transfected with pTRIM21-GST or control plasmid (used as a negative control). Immunoblot analysis of TRIM21, RIPK1, RIPK3, and MLKL expressions was carried out 72 h after transfection. Anti-human Hsc70 antibody was used as protein loading control. Representative data of three independent experiments. (D) Forty eight hours after transfection, HT29, and HaCat cells were treated (in grey) or not (in white) with TRAIL-SK (100 ng/ml), z-VAD-fmk (25 µM), and Birinapant (Bp, 1 µM) (TzB) for 24 h. Percentages of necrotic cells (propidium iodide (PI) positive) were estimated (means ± SD, n = 3). (###), p < 0.001 compared treated cells to NT cells; (*), p < 0.05, and (**), p < 0.01 compared treated conditions.
Techniques Used: Over Expression, Expressing, Transfection, Negative Control, Western Blot, Plasmid Preparation

Figure Legend Snippet: TRIM21-KO HT29 cells are more resistant to TRAIL/z-VAD-fmk/Birinapant (TzB)-induced necroptosis and their sensitivity can be rescued by TRIM21 re-expression. (A) WT (black lines) or TRIM21-KO (grey lines) HT29 cells were treated (dashed lines) or not (solid lines) with TRAIL-SK (100 ng/ml), z-VAD-fmk (25 µM), and Birinapant (Bp, 1 µM) (TzB) during 8 h. Necroptosis was evaluated by measuring SYTOX™ Green (SG) intensity (RFU) as described in materials and methods. Representative data of three independent experiments. (B) WT and TRIM21-KO HT29 cells were treated with TzB during the indicated times. Immunoblot analysis of TRIM21, RIPK1, RIPK3, MLKL, and phosphorylated forms of RIPK1, RIPK3, and MLKL were evaluated. Anti-human Hsc70 antibody was used as protein loading control. Representative data of three independent experiments. (C) TRIM21-KO HT29 cells were transfected with EGFP-control plasmid or TRIM21-EGFP plasmid for 48 h and approximately 40% of cells were GFP positive for each transfection conditions. Immunoblot analysis of TRIM21, RIPK1, RIPK3 and, MLKL expressions was carried out 48 h after transfection. Anti-human Hsc70 antibody was used as protein loading control. (D) After transfection with the EGFP-control plasmid (black lines) or with the pTRIM21-EGFP (grey lines), cells were treated or not (NT, solid lines) with TRAIL-SK (100 ng/ml), z-VAD-fmk (25 µM), and Birinapant (Bp, 1 µM) (TzB, dashed lines) during 8 h. Necroptosis was evaluated by measuring propidium iodide (PI) intensity (RFU) as described in materials and methods (means ± SEM, n = 3). (*), p < 0.05 compared treated conditions.
Techniques Used: Expressing, Western Blot, Transfection, Plasmid Preparation
rabbit polyclonal anti ripk3 (ProSci Incorporated)


Structured Review

Rabbit Polyclonal Anti Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis"
Article Title: Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis
Journal: Cell
doi: 10.1016/j.cell.2020.02.050

Figure Legend Snippet: (A) IAV-induced cell death kinetics in primary wild-type (WT), Zbp1−/−, and Ripk3−/− MEFs.
Techniques Used:

Figure Legend Snippet: (A) IAV-infected (PR8, MOI = 2) WT MEFs were lysed at the indicated times p.i., separated into nuclear and cytoplasmic fractions, and examined for ZBP1, MLKL, RIPK3, and viral proteins by immunoblotting. Immunoblotting for GAPDH and histone H3 was used to confirm purity of cytoplasmic and nuclear fractions.
Techniques Used: Infection, Western Blot
![... (C57BL/6J) (n = 9), Zbp1−/− (n = 9), Ripk3−/− (n = 9), and Mlkl−/− (n = 8) ... (A) Survival analysis of age- and sex-matched WT (C57BL/6J) (n = 9), Zbp1−/− (n = 9), Ripk3−/− (n = 9), and Mlkl−/− (n = 8) mice infected with a modestly lethal (~LD20) dose of IAV (PR8, 2,500 EID50/mouse intranasally [i.n.]).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3753/pmc07153753/pmc07153753__nihms-1567937-f0008.jpg)
Figure Legend Snippet: (A) Survival analysis of age- and sex-matched WT (C57BL/6J) (n = 9), Zbp1−/− (n = 9), Ripk3−/− (n = 9), and Mlkl−/− (n = 8) mice infected with a modestly lethal (~LD20) dose of IAV (PR8, 2,500 EID50/mouse intranasally [i.n.]).
Techniques Used: Infection

Figure Legend Snippet: KEY RESOURCES TABLE
Techniques Used: Recombinant, Enzyme-linked Immunosorbent Assay, SYBR Green Assay, Immunoprecipitation, RNA Sequencing Assay, Plasmid Preparation, Software
anti ripk3 (ProSci Incorporated)


Structured Review

Anti Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Casein kinase 1G2 suppresses necroptosis-promoted testis aging by inhibiting receptor-interacting kinase 3"
Article Title: Casein kinase 1G2 suppresses necroptosis-promoted testis aging by inhibiting receptor-interacting kinase 3
Journal: eLife
doi: 10.7554/eLife.61564

Figure Legend Snippet: ( A ) CSNK1s associate with RIPK3. The HT29-HA-3×Flag-RIPK3 cell lysates were immunoprecipitated using anti-Flag resin. The pull-down protein mixture was subjected to mass spectrometry analysis and the identified casein kinase was shown. ( B ) Measurement of the effect of co-expressed casein kinase members on RIPK3 kinase activity. Cultured 293T cells were co-transfected with Flag-tagged RIPK3 and indicated Myc-tagged CSNK1A1, CSNK1A1-L, CSNK1D1, CSNK1D2, CSNK1G1, CSNK1G2, CSNK1E, CSNK2A1, CSNK2A2, and CSNK2B for 20 hr. The cell extracts were then subjected to western blotting analysis using antibodies against Myc-tag, Flag-tag, β-actin, and phosphor-S227-RIPK3 as indicated. Numbers on the right indicate molecular weight markers (kDa). ( C ) Measurement of the effect of co-expression casein kinase 1G members on RIPK3 kinase activity. Cultured 293T cells were co-transfected with Flag-tagged RIPK3 and indicated Myc-tagged CSNK1G1, CSNK1G2, and CSNK1G3 for 20 hr. The cell extracts were then subjected to western blotting analysis using antibodies against Myc-tag, Flag-tag, β-actin, and phosphor-S227-RIPK3 as indicated. ( A and B ) The necroptotic effect of knockout Csnk1g2 in MEFs. Cultured parental MEF cells (WT) and MEF cells with their Csnk1g2 knocked out (KO) were treated with the indicated necroptotic stimuli for 12 hr. The cell viability of these necroptotic stimuli-treated cells was then measured using Cell-titer Glo in ( A ). Data are mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. LPS 2 ng/ml, TRAIL 20 ng/ml. The cell extracts were then subjected to western blotting analysis using antibodies against RIP1, phosphor-S232-RIPK3 (p-RIPK3), β-actin, MLKL, and phosphor-S345-MLKL as indicated in ( B ).
Techniques Used: Immunoprecipitation, Mass Spectrometry, Activity Assay, Cell Culture, Transfection, Western Blot, FLAG-tag, Molecular Weight, Expressing, Knock-Out

Figure Legend Snippet: ( A ) Western blotting analysis using antibodies against the indicated proteins. Cultured 293 T cells were transfected with Flag-tagged RIPK3 and the indicated versions of Myc-tagged CSNK1G2, including wild-type (WT) and two kinase-dead point mutants K75A and D165N for 20 hr. Cell extracts were then prepared and used for western blotting analysis. Vec, vector control. Numbers on the right indicate molecular weight markers (kDa). ( B ) Top: Cell viability as measured by Cell Titer-Glo. Cultured MEF with wild-type Csnk1g2 gene (WT) or with their Csnk1g2 gene knocked out (KO) followed by transfection with vector control (Vec) or indicated wild-type or a kinase-dead (K75A) mutant CSNK1G2 MEF. The cells were then treated with DMSO or TSZ as indicated for 12 hr before the intracellular ATP levels were measured by Cell Titer-Glo. T denotes 20 ng/ml TNF-α; S, denotes 100 nM Smac mimetic; Z denotes 20 μM Z-VAD-FMK. Data are mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. Bottom: Aliquots of these treated cells were used for western blotting analysis using an antibody against CSNK1G2. ( C ) Western blotting of necroptosis activation markers phospho-RIPK3 (p-RIPK3) and phospho-MLKL (p-MLKL). Cultured MEF cells with indicated CSNK1G2 gene as in ( B ) were treated with indicated stimuli for 4 hr before the cell extracts were prepared and subjected to western blotting analysis as indicated. ( D and E ) Western blotting analysis of RIPK3-associated RIPK1 and CSNK1G2. Immunoprecipitates using an anti-Flag antibody from extracts of MEF-Flag-RIPK3 and MEF ( Csnk1g2 −/− )-Flag-RIPK3 cells (D) or HeLa-HA-3×Flag-RIPK3-Myc-CSNK1G2(WT and K75A) cells ( E ) treated with the indicated stimuli for 6 hr were subjected to western blotting analyzing using antibodies as indicated. (F) Cell viability measurement of bone marrow-derived macrophages from the wild-type (WT) or Csnk1g2 knockout mice. Macrophages were isolated from the WT or Csnk1g2 knockout mice (KO) and treated with the indicated necroptosis stimuli for 12 hr, and the cell viability was measured by Cell-Titer Glo. Trail: TNF-related apoptosis-inducing ligand. LPS: Lipopolysaccharide. Data are mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. ( G ) Kaplan–Meier plot of survival of male Csnk1g2 +/+ (WT), Csnk1g2 −/− ( Csnk1g2 knockout littermates), or Ripk3 −/− ( Ripk3 gene knockout) mice (n = 10 for each genotype, age: 3 months) injected intraperitoneally with one dose of murine TNF-α (300 μg/kg). Body temperature was measured with a lubricated rectal thermometer. Mice with a temperature below 23°C were euthanized for ethical reasons. Generation of Csnk1g2 −/− mice.
Techniques Used: Western Blot, Cell Culture, Transfection, Plasmid Preparation, Molecular Weight, Mutagenesis, Activation Assay, Derivative Assay, Knock-Out, Isolation, Gene Knockout, Injection

Figure Legend Snippet: ( A and B ) The necroptotic effect of knockout Csnk1g2 in MEFs. Cultured parental MEF cells (WT) and MEF cells with their Csnk1g2 knocked out (KO) were treated with the indicated necroptotic stimuli for 12 hr. The cell viability of these necroptotic stimuli-treated cells was then measured using Cell-titer Glo in ( A ). Data are mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. LPS 2 ng/ml, TRAIL 20 ng/ml. The cell extracts were then subjected to western blotting analysis using antibodies against RIP1, phosphor-S232-RIPK3 (p-RIPK3), β-actin, MLKL, and phosphor-S345-MLKL as indicated in ( B ). ( C ) Cultured MEF cells with their Csnk1g2 gene knocked out ( Csnk1g2 −/− ) were co-transfected with cDNAs encoding Myc-tagged wild-type (WT) CSNK1G2 or kinase-dead mutant (K75A) as indicated and Flag-RIP3 for 24 hr. The cell extracts were then subjected to western blotting analysis directly (Input), or immunoprecipitation with anti-Flag antibody and the precipitates were subjected to western blotting analysis using antibodies against Myc-tag, Flag-tag, and β-actin as indicated. ( D ) The effect of WT and kinase-dead mutant of CSNK1G2 on RIPK3 dimerization-induced necroptosis. Cultured NIH3T3-Flag-RIPK3-Myc-CSNK1G2(Vec, WT, and K75A) cells were treated with the FKBP dimerizer molecule AP20187 for 12 hr. The cell extracts were subsequently subjected to western blotting analysis using antibodies against Myc-tag, Flag-tag, and β-actin as indicated (lower panel). The cell viability was measured by Cell-titer Glo. Data are mean ± SD of triplicate wells.
Techniques Used: Knock-Out, Cell Culture, Western Blot, Transfection, Mutagenesis, Immunoprecipitation, FLAG-tag

Figure Legend Snippet: ( A ) MS/MS spectrum of CSNK1G2 phosphorylation sites. The identified phosphorylated peptide to be EHK P SLTG P TAR with S211 and T215 as the phosphorylated amino acid residues. The b- and y-type product ions are indicated in the spectrum. Data are related to those in . ( B ) Effect on RIPK3 auto-phosphorylation by co-expression of the indicated version of CSNK1G2. Cultured 293 T cells were transfected with Flag-tagged RIPK3 cDNA together with indicated Myc-tagged wild-type (WT) CSNK1G2, or kinase-dead mutant K75A, or phosphorylation site-resistant mutant S211A/T215A for 20 hr. The cell extracts were then subjected to western blotting analysis using antibodies against phospho-S227-RIPK3, Flag-RIPK3, and Myc-CSNK1G2 as indicated. ( C ) Top: Cell viability measurement of effect of phosphorylation sites mutant CSNK1G2 on necroptosis. Cultured WT MEF or MEF with their Csnk1g2 gene knocked out (KO) were transfected with either vector control (Vec) or cDNA encoding WT Csnk1g2 or phosphorylation sites mutant (S211A/T215A) followed by treatment of DMSO or necroptotic stimuli TSZ as indicated for 12 hr. The cell viability was measured by Cell-titer Glo. Data are mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. Bottom: Aliquots of these treated cells were used to make cell extracts for western blotting analysis using an antibody against CSNK1G2 protein. The effect of CSNK1G2 on RIPK1/RIPK3 interaction as measured by co-IP. Cultured HeLa-HA-3×Flag-RIPK3 cells were transfected with either vector control (Vec) or WT or phosphorylation site mutant Myc-CSNK1G2 (S211A/T215A) as indicated. The cells were then treated with DMSO or necroptosis stimuli TSZ for 6 hr. The cell extracts were prepared and subjected to immunoprecipitation with an anti-Flag antibody. The extracts (Input) and the immunoprecipitates (IP: Flag) were then subjected to western blotting analysis using antibodies as indicated.
Techniques Used: Tandem Mass Spectroscopy, Expressing, Cell Culture, Transfection, Mutagenesis, Western Blot, Plasmid Preparation, Co-Immunoprecipitation Assay, Immunoprecipitation

Figure Legend Snippet: ( A ) Identification of auto-phosphorylation sites on CSNK1G2. Myc-tagged wild-type (WT) CSNK1G2 or its kinase-dead mutant (K75A) was co-transfected with Flag-RIP3 in 293 T cells for 24 hr. CSNK1G2 was immunoprecipitated using anti-Myc resins. The CSNK1G2 (WT, K75A) bands were excised and analyzed by MS/MS. The identified phosphorylated peptides were shown in the table with the phosphorylated amino acid residues highlighted in red. No phosphorylated peptide was identified in CSNK1G2 (K75A) sample. ( B ) The effect of phosphorylation sites mutants CSNK1G2 on RIPK3 kinase activity. Cultured 293 T cells were transfected with vector control (Vec) or Flag-tagged RIPK3 and Myc-tagged WT, or kinase-dead (K75A) or different phosphorylation site mutants as indicated (S26A/S27A, S211A/T215A, and S381A) for 20 hr. The cell extracts were then subjected to western blotting analysis using antibodies against Flag-tag, Myc-tag, phosphor-Serine227-RIPK3, and β-actin as indicated. ( C ) The effect of S211A and T215A mutants of CSNK1G2 on RIPK3 kinase activity. Cultured 293 T cells were transfected with vector control (Vec) or Flag-tagged RIPK3 and Myc-tagged WT, or a kinase-dead mutant (K75A), or S211A or T215A mutants for 20 hr. The cell extracts were then subjected to western blotting analysis using antibodies against Flag-tag, Myc-tag, phosphor-Serine227-RIPK3, and β-actin as indicated. ( D ) Alignment of amino acid sequences around the auto-phosphorylation sites of CSNK1G2 in four vertebrate species. The Serine 211 and Threonine 215 (human origin) residues are denoted by asterisks (*). The numbers on the right indicate the corresponding histidine in CSNK1G2 of indicated species.
Techniques Used: Mutagenesis, Transfection, Immunoprecipitation, Tandem Mass Spectroscopy, Activity Assay, Cell Culture, Plasmid Preparation, Western Blot, FLAG-tag

Figure Legend Snippet: ( A ) The expression of CSNK1G2 in mouse testis, lung, large intestine, small intestine, spleen, kidney, heart, brain, liver, and ovary tissues (n = 3, 2 months). The indicated tissue extracts were subjected to western blotting analysis using antibodies against CSNK1G2 and GAPDH as indicated. ( B ) The expression of RIPK3 and CSNK1G2 in mouse testis. The testis sections of 2-month-old wild-type mice (n = 3) were stained sequentially with antibodies against RIPK3 and CSNK1G2 followed by fluorescent-conjugated secondary antibody. Counterstaining with DAPI, blue. Scale bar on the upper panel is 100 μm. The areas marked by the yellow boxes on the upper panel were shown in the lower panel. ( C ) The sensitivity of primary cells from the seminiferous tubules of Csnk1g2 − /− and Csnk1g2 +/+ testis to necroptosis induction. The cells from the seminiferous tubules of 2-month-old littermates with indicated genotype were isolated and cultured in vitro before treated with DMSO or TSZ as indicated for 12 hr. The cell viability was then measured by Cell-Titer Glo. Data are mean ± SD of triplicate wells. ***p<0.001. p-values were determined by two-sided unpaired Student’s t- tests. ( D ) Western blotting analysis of CSNK1G2 interaction with RIPK3 in mouse testis. The wild-type and Csnk1g2 knockout testis (3 months) were ground and resuspended in lysis buffer, homogenized for 30 s with a Paddle Blender. The supernatants were collected, and CSNK1G2 was immunoprecipitated using anti-CSNK1G2 antibody. The immunocomplexes and lysates were analyzed by western blotting using antibodies as indicated. Each group was from a pool of three mice. ( E ) The expression of RIPK3, CSNK1G2, and RIPK1 proteins in GC-2spd, 15 P-1, and MA-10 cells. The extracts from the indicated cultured cells were subjected to western blotting analysis using antibodies against RIPK3, CSNK1G2, RIPK1, and GAPDH as indicated. ( F and G ) The effect of CSNK1G2 on necroptosis of GC-2spd and 15 P-1 cells. Cultured parental GC-2spd (f) or 15 P-1 cells (g) (WT), and GC-2spd or 15 P-1 cells with their Csnk1g2 gene knocked out ( Csnk1g2 −/− ) were treated with DMSO or TSZ as indicated for 4 hr. The cell viability was measured by Cell-titer Glo. Data are mean ± SD of triplicate wells. **p<0.01, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. Bottom, immunoblot of CSNK1G2. Cell extracts from aliquots of these cells were also subjected to western blotting analysis using antibodies against CSNK1G2 and GAPDH as indicated, and the results were shown at the bottom.
Techniques Used: Expressing, Western Blot, Staining, Isolation, Cell Culture, In Vitro, Knock-Out, Lysis, Immunoprecipitation

Figure Legend Snippet: The GC-2spd, 15 P-1, and MA-10 cells cultured on cover slides were sequentially stained with antibodies against RIPK3 and CSNK1G2 followed by secondary antibodies conjugated with red (RIPK3) or green (CSNK1G2). Counterstaining with DAPI, blue. Scale bar, 10 μm.
Techniques Used: Cell Culture, Staining

Figure Legend Snippet: ( A ) Body weights of Csnk1g2 +/+ and Csnk1g2 −/− male littermate mice when they were 2 and 12 months old (n = 10 for each genotype). ( B and C ) Macroscopic features ( B ) and weights ( C ) of seminal vesicles from Csnk1g2 +/+ and Csnk1g2 −/− male littermate mice (n = 10 for each genotype) at the indicated ages. ( D and E ) Macroscopic features ( D ) and weights ( E ) of testes from Csnk1g2 +/+ and Csnk1g2 −/− male littermate mice (n = 12 for each genotype) at the indicated ages. ( F ) H&E staining sections of testis from Csnk1g2 +/+ and Csnk1g2 −/− male littermate mice (n = 10 for each genotype) at the indicated ages. The number of empty seminiferous tubules was counted based on H&E staining, and the percentage of empty seminiferous tubules of each group is labeled in the upper left corner of the images. Scale bar, 200 μm. ( G and H ) Immunohistochemical staining (IHC) of testes from Csnk1g2 +/+ and Csnk1g2 −/− male littermate mice (n = 6 for each genotype) with phospho-MLKL (p-MLKL) antibody in ( G ). p-MLKL positive cells were counted in five fields per testis and quantified in ( H ). Scale bar, 100 μm. ( I ) Western blotting analysis of extracts from phosphate-buffered saline (PBS) perfused testes of Csnk1g2 +/+ (WT) and Csnk1g2 −/− (KO) male littermate mice of 2 and 12 months of age using antibodies against CSNK1G2, RIPK1, RIPK3, MLKL, and phospho-MLKL (p-MLKL) and β-actin as indicated. The number on the right is markers of molecular weight (kDa). Each group was from a pool of three mice. ( J ) Summary of fertility rates of Csnk1g2 +/+ and Csnk1g2 −/− male littermate mice (n = 12). Each male mice of 2 or 12 months of age was housed in the same cage with a pair of 10-week-old wild-type female mice for 2 months; females were replaced every 2 weeks. The number of male mice with reproduction capacity was counted. p-values were determined using Fisher’s exact tests (unpaired, two-tailed). All quantified data in the figure except (J) represent the mean ± SEM. *p<0.05, **p<0.01, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. NS, not significant.
Techniques Used: Staining, Labeling, Immunohistochemical staining, Western Blot, Molecular Weight, Two Tailed Test

Figure Legend Snippet: ( A ) The body weights of 12-month-old Csnk1g2 +/+ , Csnk1g2 −/− , and Csnk1g2 −/− fed with a RIPK1 kinase inhibitor (RIPA-56)-containing diet, and Csnk1g2 −/− Ripk3 −/− male littermate mice (n = 10 for each genotype). ( B ) The weights of seminal vesicles from 12-month-old Csnk1g2 +/+ , Csnk1g2 −/− , Csnk1g2 −/− +RIPA-56, and Csnk1g2 −/− Ripk3 −/− male littermate mice (n = 10 for each genotype). ( C ) The weights of testes from 12-month-old Csnk1g2 +/+ , Csnk1g2 −/− , Csnk1g2 −/− +RIPA-56, and Csnk1g2 −/− Ripk3 −/− male littermate mice (n = 10 for each genotype). ( D ) H&E staining of testis sections from 12-month-old Csnk1g2 +/+ , Csnk1g2 −/− , Csnk1g2 −/− +RIPA-56, and Csnk1g2 −/− Ripk3 −/− male littermate mice (n = 10 for each genotype). The number of empty seminiferous tubules was counted based on H&E staining, and the percentage of empty seminiferous tubules was labeled in the upper left corner of the images: scale bar, 200 μm. ( E and F ) IHC staining of testes from 12-month-old Csnk1g2 +/+ , Csnk1g2 −/− , Csnk1g2 −/− +RIPA-56, and Csnk1g2 −/− Ripk3 −/− male littermate mice (n = 8 for each genotype) with an anti-phospho-MLKL (p-MLKL) antibody ( E ). p-MLKL positive cells were counted in five fields per testis and quantified in ( F ). Scale bar, 100 μm. ( G ) Summary of the fertility rates of 12-month-old Csnk1g2 +/+ , Csnk1g2 −/− , Csnk1g2 −/− +RIPA-56, and Csnk1g2 −/− Ripk3 −/− male littermate mice (n = 10 for each genotype). Each male mouse was caged with a pair of 10-week-old wild-type female mice for 2 months; females were replaced every 2 weeks. The number of male mice with reproduction capacity was counted. p-values were determined using Fisher’s exact tests (unpaired, two-tailed). Csnk1g2 −/− +RIPA-56 mice: Csnk1g2 −/− male mice were fed with AIN93G or AING3G containing RIPA-56 (RIPA-56: 300 mg/kg) for 10 months started when they were 2 months old in an SPF facility. All quantified data in the figure except ( G ) represent the mean ± SEM. **p<0.01, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. NS, not significant.
Techniques Used: Staining, Labeling, Immunohistochemistry, Two Tailed Test

Figure Legend Snippet: ( A ) Macroscopic features of a typical 12-month-old seminal vesicle from Csnk1g2 +/+ , Csnk1g2 −/− , Csnk1g2 −/− +RIPA-56, and Csnk1g2 −/− Ripk3 −/− male littermate mice (n = 10 for each genotype examined). ( B ) Macroscopic features of a typical 12-month testes from Csnk1g2 +/+ , Csnk1g2 −/− , Csnk1g2 −/− +RIPA-56, and Csnk1g2 −/− Ripk 3 −/− male littermate mice (n = 10 for each genotype examined). ( C ) Body weights of 3-month-old Csnk1g2 +/+ , Csnk1g2 −/− , Csnk1g2 −/− +RIPA-56, and Csnk1g2 −/− Ripk 3 −/− male mice (n = 10 for each genotype). p-values were determined by two-sided unpaired Student’s t -tests. NS, not significant.
Techniques Used:

Figure Legend Snippet: ( A–D ) Serum hormonal levels of 3-month-old Csnk1g2 +/+ , Csnk1g2 −/− , Csnk1g2 −/− +RIPA-56, and Csnk1g2 −/− Ripk3 −/− male littermate mice. Littermates of male mice with the indicated genotype were killed, and the indicated hormone levels in serum were measured using ELISA kit for each hormone (n = 8 for each genotype). Data represent the mean ± SEM. **p<0.01, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. Csnk1g2 −/− +RIPA-56 mice: 2-month-old Csnk1g2 −/− male mice were fed with AIN93G or AING3G containing RIPA-56 (RIPA-56: 300 mg/kg) for 1 month in an SPF facility before used. ( E–H ) Serum hormonal levels of 12-month-old Csnk1g2 +/+ , Csnk1g2 −/− , Csnk1g2 −/− +RIPA-56, and Csnk1g2 −/− Ripk 3 −/− male littermate mice. Littermates of 12-month-old male mice with the indicated genotype were killed, and the indicated hormone levels in serum were measured using ELISA kit for each hormone (n = 8 for each genotype). Data represent the mean ± SEM. **p<0.01, ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests. Csnk1g2 −/− +RIPA-56 mice: 2-month-old Csnk1g2 −/− male mice were fed with AIN93G or AING3G containing RIPA-56 (RIPA-56: 300 mg/kg) for 10 months in an SPF facility.
Techniques Used: Enzyme-linked Immunosorbent Assay

Figure Legend Snippet: ( A ) Expression of CSNK1G2 and RIPK3 in human testes. Sections from a testis sample of a 30-year-old human patient were stained sequentially with antibodies against CSNK1G2 and RIPK3 as indicated followed by green or red fluorescent-conjugated secondary antibodies as indicated. Counterstaining with DAPI, blue. Scale bar, 50/100 μm. Yellow boxes in the upper panels were shown in the lower panels. The experiment was repeated three times with three different patients. ( B and C ) H&E staining of testes from young and old men. Young man testes (25–30 years, n = 10; from testicular torsion necrosis patients) and old man testes (80–89 years, n = 15; from prostate cancer patients) were sectioned and stained with H&E in ( B ). The number of empty seminiferous tubules was counted based on H&E staining and quantification in ( C ); empty seminiferous tubules were counted in five fields per testis. Scale bar, 100 μm. ( D and E ) IHC of testes from young and old men with phosphor-Serine358-MLKL antibody (p-MLKL). Young man testes (25–30 years, n = 10; from testicular torsion necrosis patients) and old man testes (80–89 years, n = 15; from prostate cancer patients) were sectioned and stained with an antibody against phosphor-Serine358-MLKL antibody ( D ). p-MLKL + cells were counted in five fields per testis and quantification in ( E ). Scale bar, 100 μm. All quantified data in the figure represent the mean ± SEM. ***p<0.001. p-values were determined by two-sided unpaired Student’s t -tests.
Techniques Used: Expressing, Staining

Figure Legend Snippet: Necroptosis induced by TNF-α is initiated by the necrosome formation, a protein complex containing both RIPK1 and RIPK3. CSNK1G2 blocks necrosome formation through binding RIPK3 and preventing RIPK3 activation. CSNK1G2 binding to RIPK3 is triggered by an autophosphorylation at serine211/threonine 215 sites in its kinase domain. Csnk1g2 knockout mice showed enhanced necroptosis response and premature aging of their testis.
Techniques Used: Binding Assay, Activation Assay, Knock-Out

Figure Legend Snippet:
Techniques Used: Recombinant, Plasmid Preparation, Software
ripk3 (ProSci Incorporated)


Structured Review
![Casp8 DA MEFs are selectively resistant to IAV-induced apoptosis. (A) <t>ZBP1-RIPK3–dependent</t> cell death pathways activated by IAV. Apoptosis is mediated by RIPK1/FADD-dependent activation of Casp8. (B) Casp8 domain organization and knock-in mutation (D387A) in Casp8 DA mice. DED, death effector domain. (C) MEFs were treated with murine TRAIL (100 ng/ml) in the presence of cycloheximide (CHX; 250 ng/ml), and cell viability was determined at 24 h. n = 3 replicates per condition; data are from one of four experiments with similar results. (D) Photomicrographs of WT and Casp8 DA MEFs infected with PR8 (multiplicity of infection [MOI]), 2) in the presence or absence of RIPK3 inhibitor GSK’843 (5 µM) or treated with TRAIL (100 ng/ml) + CHX (250 ng/ml) for 24 h. Scale bar = 100 µm. (E) WT, Casp8 DA , or Mlkl −/− MEFs were infected with PR8 (MOI, 2) and exposed to the indicated inhibitors, and cell viability was determined at 24 h postinfection (h.p.i.). n = 3 replicates per condition; data are from one of four experiments with similar results. (F) Cell death kinetics after PR8 infection (MOI, 2) of MEFs from the indicated genotypes. n = 3 replicates per condition; data are from one of six experiments with similar results. (G) WT and Casp8 DA MEFs were infected with PR8 (MOI, 2 or 5) and examined for the indicated proteins at 24 h. Molecular weights in kilodaltons are shown to the left. Results are representative of three independent experiments. Unpaired Student’s t test (C and E); two-way ANOVA and Tukey’s multiple comparisons test (F). Error bars represent mean ± SD; **, P < 0.005; ****, P < 0.00005.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6817/pmc07596817/pmc07596817__JEM_20191259_Fig1.jpg)
Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Necroptosis restricts influenza A virus as a stand-alone cell death mechanism"
Article Title: Necroptosis restricts influenza A virus as a stand-alone cell death mechanism
Journal: The Journal of Experimental Medicine
doi: 10.1084/jem.20191259
![... MEFs are selectively resistant to IAV-induced apoptosis. (A) ZBP1-RIPK3–dependent cell death pathways activated by IAV. Apoptosis is ... Casp8 DA MEFs are selectively resistant to IAV-induced apoptosis. (A) ZBP1-RIPK3–dependent cell death pathways activated by IAV. Apoptosis is mediated by RIPK1/FADD-dependent activation of Casp8. (B) Casp8 domain organization and knock-in mutation (D387A) in Casp8 DA mice. DED, death effector domain. (C) MEFs were treated with murine TRAIL (100 ng/ml) in the presence of cycloheximide (CHX; 250 ng/ml), and cell viability was determined at 24 h. n = 3 replicates per condition; data are from one of four experiments with similar results. (D) Photomicrographs of WT and Casp8 DA MEFs infected with PR8 (multiplicity of infection [MOI]), 2) in the presence or absence of RIPK3 inhibitor GSK’843 (5 µM) or treated with TRAIL (100 ng/ml) + CHX (250 ng/ml) for 24 h. Scale bar = 100 µm. (E) WT, Casp8 DA , or Mlkl −/− MEFs were infected with PR8 (MOI, 2) and exposed to the indicated inhibitors, and cell viability was determined at 24 h postinfection (h.p.i.). n = 3 replicates per condition; data are from one of four experiments with similar results. (F) Cell death kinetics after PR8 infection (MOI, 2) of MEFs from the indicated genotypes. n = 3 replicates per condition; data are from one of six experiments with similar results. (G) WT and Casp8 DA MEFs were infected with PR8 (MOI, 2 or 5) and examined for the indicated proteins at 24 h. Molecular weights in kilodaltons are shown to the left. Results are representative of three independent experiments. Unpaired Student’s t test (C and E); two-way ANOVA and Tukey’s multiple comparisons test (F). Error bars represent mean ± SD; **, P < 0.005; ****, P < 0.00005.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6817/pmc07596817/pmc07596817__JEM_20191259_Fig1.jpg)
Figure Legend Snippet: Casp8 DA MEFs are selectively resistant to IAV-induced apoptosis. (A) ZBP1-RIPK3–dependent cell death pathways activated by IAV. Apoptosis is mediated by RIPK1/FADD-dependent activation of Casp8. (B) Casp8 domain organization and knock-in mutation (D387A) in Casp8 DA mice. DED, death effector domain. (C) MEFs were treated with murine TRAIL (100 ng/ml) in the presence of cycloheximide (CHX; 250 ng/ml), and cell viability was determined at 24 h. n = 3 replicates per condition; data are from one of four experiments with similar results. (D) Photomicrographs of WT and Casp8 DA MEFs infected with PR8 (multiplicity of infection [MOI]), 2) in the presence or absence of RIPK3 inhibitor GSK’843 (5 µM) or treated with TRAIL (100 ng/ml) + CHX (250 ng/ml) for 24 h. Scale bar = 100 µm. (E) WT, Casp8 DA , or Mlkl −/− MEFs were infected with PR8 (MOI, 2) and exposed to the indicated inhibitors, and cell viability was determined at 24 h postinfection (h.p.i.). n = 3 replicates per condition; data are from one of four experiments with similar results. (F) Cell death kinetics after PR8 infection (MOI, 2) of MEFs from the indicated genotypes. n = 3 replicates per condition; data are from one of six experiments with similar results. (G) WT and Casp8 DA MEFs were infected with PR8 (MOI, 2 or 5) and examined for the indicated proteins at 24 h. Molecular weights in kilodaltons are shown to the left. Results are representative of three independent experiments. Unpaired Student’s t test (C and E); two-way ANOVA and Tukey’s multiple comparisons test (F). Error bars represent mean ± SD; **, P < 0.005; ****, P < 0.00005.
Techniques Used: Activation Assay, Knock-In, Mutagenesis, Infection

Figure Legend Snippet: Characterization of virus replication in cells and in vivo. (A) Quantification of NP signal intensity in IAV-infected WT MEFs (PR8; MOI, 2; 18 h.p.i.) that are either pMLKL + or CC3 + . Of note, a few apoptotic (i.e., CC3 + ) cells showed a markedly intense NP signal, likely because they had shrunk in size (characteristic of apoptosis) and therefore harbor a more condensed pool of NP. Data are pooled from three fields with 6–10 cells/field; data are from one of four experiments with similar results. (B) HT-29 FLAG-ZBP1 cells were produced by retroviral transduction of an expression vector encoding FLAG-tagged human ZBP1 into the HT-29 cell line. These cells, but not control cells expressing an empty vector (EV), underwent rapid cell death upon infection with PR8 (MOI, 2). IAV-induced cell death was dependent on ZBP1-RIPK3 signaling, shown by rescue with the combination of RIPK3i (GSK’843; 5 µM) + zVAD (50 µM). n = 3 replicates per condition; data are from one of six experiments with similar results. (C) Lung virus titers of mice of the indicated genotypes at 3 d.p.i. (left) or at 5 d.p.i (right) with PR8 (1,500 EID 50 ). WT, n = 4; Casp8 DA , n = 3; Mlkl −/− , n = 5; Casp8 DA Mlkl −/− , n = 3 for D3. WT, n = 4; Casp8 DA , n = 4; MlKl −/− , n = 5; Casp8 DA MlKl −/− , n = 4 for D5. (D) Kinetics of IAV (PR8; MOI, 2) replication in MEFs of the indicated genotypes as determined by quantitative RT-PCR analysis of PA segment levels. n = 3 replicates per condition; data are from one of six experiments with similar results. Unpaired Student’s t test (A and D); two-way ANOVA with Tukey’s multiple comparisons test (B); Mann-Whitney test (C). Error bars represent mean ± SD. *, P < 0.05; **, P < 0.005; ***, P < 0.0005.
Techniques Used: In Vivo, Infection, Produced, Transduction, Expressing, Plasmid Preparation, Quantitative RT-PCR, MANN-WHITNEY
ripk3 (ProSci Incorporated)


Structured Review

Ripk3, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ripk3/product/ProSci Incorporated
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "MLKL and FADD Are Critical for Suppressing Progressive Lymphoproliferative Disease and Activating the NLRP3 Inflammasome"
Article Title: MLKL and FADD Are Critical for Suppressing Progressive Lymphoproliferative Disease and Activating the NLRP3 Inflammasome
Journal: Cell reports
doi: 10.1016/j.celrep.2016.06.103

Figure Legend Snippet: (A and C) Wild-type, Ripk3−/−, Mlkl−/−, Ripk3−/−Fadd−/−, and Mlkl−/−Fadd−/− BMDMs were primed with (A) 20 ng/ml LPS or (C) 100 mg/ml Poly(I:C) for 5 hr prior to 30-min treatment of 5 mM ATP. Supernatants were analyzed by immunoblot for caspase-1 activation.
Techniques Used: Western Blot, Activation Assay

Figure Legend Snippet: (A) Wild-type, Ripk3−/−, Mlkl−/−, Ripk3−/−Fadd−/−, and Mlkl−/−Fadd−/− BMDMs or for 5 hr prior to 30-min treatment of 5 mM ATP. Supernatants and cell pellets were analyzed by immunoblot for ASC polymerization. Cell lysates were analyzed by immunoblot for the expression of ASC and NLRP3.
Techniques Used: Western Blot, Expressing

Figure Legend Snippet: (A–C) Wild-type, Ripk3−/−Fadd−/−, and Mlkl−/−Fadd−/− BMDMs were treated with 20 ng/ml LPS for 6 hr, and mRNA levels of NLRP3 (A), IL-1β (B), and ASC (C) were determined by qPCR.
Techniques Used: